| 臺大學術典藏 |
2021-03-09T01:43:14Z |
Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy
|
Yang H.-I.; Yeh M.-L.; Wong G.L.; Peng C.-Y.; Chen C.-H.; Trinh H.N.; Cheung K.-S.; Xie Q.; TUNG-HUNG SU; Kozuka R.; Lee D.-H.; Ogawa E.; Zhao C.; Ning H.-B.; Huang R.; Li J.; Zhang J.Q.; Ide T.; Xing H.; Iwane S.; Takahashi H.; Wong C.; Wong C.; Lin C.-H.; Hoang J.; Le A.; Henry L.; Toyoda H.; Ueno Y.; Gane E.J.; Eguchi Y.; Kurosaki M.; Wu C.; Liu C.; Shang J.; Furusyo N.; Enomoto M.; Kao J.-H.; Yuen M.-F.; Yu M.-L.; Nguyen M.H. |
| 臺大學術典藏 |
2021-03-09T01:43:13Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan
|
Liu C.-H.; Liu C.-J.; Hung C.-C.; Hsieh S.-M.; TUNG-HUNG SU; Sun H.-Y.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:43:13Z |
Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy
|
Tseng T.-C.; Peng C.-Y.; Hsu Y.-C.; TUNG-HUNG SU; Wang C.-C.; Liu C.-J.; Yang H.-C.; Yang W.-T.; Lin C.-H.; Yu M.-L.; Lai H.-C.; Tanaka Y.; Nguyen M.H.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:43:13Z |
Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals
|
Liu C.-H.; Lee M.-H.; Lin J.-W.; Liu C.-J.; TUNG-HUNG SU; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:43:12Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu C.-H.; Yang S.-S.; Peng C.-Y.; Lin W.-T.; Liu C.-J.; TUNG-HUNG SU; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:43:12Z |
HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis
|
Tseng T.-C.; Liu C.-J.; Chang C.T.; TUNG-HUNG SU; Yang W.-T.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:43:12Z |
Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to tenofovir disoproxil fumarate
|
Wen W.-H.; Chen H.-L.; Shih T.T.-F.; Wu J.-F.; Ni Y.-H.; Lee C.-N.; Zhao L.-L.; Lai M.-W.; Mu S.-C.; Tung Y.-C.; Hsu H.-Y.; Chang M.-H.; Shyu M.K.; Hwa H.L.; Su Y.N.; Shih J.C.; Chao K.H.; Chiu Y.C.; Chang K.C.; Liu C.J.; TUNG-HUNG SU; Chen D.S.; Chen S.M.; Lin C.C.; Lin P.Y.; Yang W.R.; Hu J.J.; Yang C.K.; Chang Y.K.; Chen K.H.; Lin H.H.; Lin Y.H.; Chen H.J.; Pan H.S.; Lau B.H.; Lee C.L.; Cheng P.J.; Chang Y.L.; Chiueh H.Y.; Wang T.H.; Hsu J.J.; Lo L.M.; Hsieh C.L.; Cheng S.W.; Tsai M.S.; Lin L.H.; She B.Q.; Peng F.S.; Lin Y.C.; Chen C.P.; Huang J.P.; Yeung C.Y.; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study) |
| 臺大學術典藏 |
2021-03-09T01:43:11Z |
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data
|
Hong C.-M.; Liu C.-H.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen Y.-W.; Kao J.-H.; Liu C.-J. |
| 臺大學術典藏 |
2021-03-09T01:43:11Z |
The clinical manifestations and management of COVID-19-related liver injury
|
TUNG-HUNG SU; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:43:11Z |
Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer
|
TUNG-HUNG SU; Tseng T.-C.; Liu C.-J.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:43:10Z |
High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy
|
Chang W.-Y.; Chiu Y.-C.; Chiu F.-W.; Hsu Y.-C.; Tseng T.-C.; Cheng P.-N.; Yang S.-S.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:43:10Z |
Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan
|
Su H.-J.; Kao J.-H.; Tseng T.-C.; Yang H.-C.; TUNG-HUNG SU; Chen P.-J.; Liu C.-J. |
| 臺大學術典藏 |
2021-03-09T01:43:10Z |
Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor in Diffuse Large B-Cell Lymphoma in the Rituximab Era
|
Cheng C.-L.; Huang S.-C.; Chen J.-H.; Wei C.-H.; Fang W.-Q.; TUNG-HUNG SU; Yuan C.-T.; Liu J.-H.; Chuang M.-K.; Tien H.-F. |
| 臺大學術典藏 |
2021-03-09T01:43:09Z |
Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in Taiwan
|
Liu C.-H.; TUNG-HUNG SU; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:43:09Z |
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis
|
Liu C.-H.; Peng C.-Y.; Fang Y.-J.; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; TUNG-HUNG SU; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:43:09Z |
A Mysterious Case of Jaundice After Development of Skin Vesicles
|
Chang K.-C.; Tsai J.-H.; TUNG-HUNG SU |
| 臺大學術典藏 |
2021-03-09T01:43:08Z |
Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load
|
Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; TUNG-HUNG SU; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen H.-H.; Chen P.-J.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:43:07Z |
Clinical manifestations and outcomes of patients with scirrhous hepatocellular carcinoma
|
Huang S.-C.; Liao S.-H.; TUNG-HUNG SU; Jeng Y.-M.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:43:07Z |
Improved second harmonic generation and two-photon excitation fluorescence microscopy-based quantitative assessments of liver fibrosis through auto-correction and optimal sampling
|
Hsiao C.-Y.; Teng X.; TUNG-HUNG SU; Lee P.-H.; Kao J.-H.; Huang K.-W. |
| 臺大學術典藏 |
2019-09-09T00:55:32Z |
Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Children With a Normal Alanine Aminotransferase Level
|
JIA-FENG WU;HUEY-LING CHEN;TUNG-HUNG SU;MEI-HWEI CHANG;PEI-JER CHEN;HONG-YUAN HSU;Chen, Ho Sheng;Xia, Ning Shao; Xia, Ning Shao; Chen, Ho Sheng; HONG-YUAN HSU; PEI-JER CHEN; MEI-HWEI CHANG; TUNG-HUNG SU; HUEY-LING CHEN; JIA-FENG WU |
| 臺大學術典藏 |
2019-09-09T00:55:32Z |
Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Children With a Normal Alanine Aminotransferase Level
|
JIA-FENG WU;HUEY-LING CHEN;TUNG-HUNG SU;MEI-HWEI CHANG;PEI-JER CHEN;HONG-YUAN HSU;Chen, Ho Sheng;Xia, Ning Shao; Xia, Ning Shao; Chen, Ho Sheng; HONG-YUAN HSU; PEI-JER CHEN; MEI-HWEI CHANG; TUNG-HUNG SU; HUEY-LING CHEN; JIA-FENG WU |
| 臺大學術典藏 |
2019-08-29T07:36:15Z |
Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy
|
HUNG-CHIH YANG; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO; JIA-HORNG KAO;DING-SHINN CHEN;PEI-JER CHEN;CHUN-JEN LIU;HUNG-CHIH YANG;Tseng, Tai-Chung;KAI-WEN HUANG;CHEN-HUA LIU;Liao, Chun-Hsun;TUNG-HUNG SU; TUNG-HUNG SU; Liao, Chun-Hsun; CHEN-HUA LIU; KAI-WEN HUANG; Tseng, Tai-Chung |
| 臺大學術典藏 |
2019-08-29T07:36:15Z |
Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy
|
HUNG-CHIH YANG; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO; JIA-HORNG KAO;DING-SHINN CHEN;PEI-JER CHEN;CHUN-JEN LIU;HUNG-CHIH YANG;Tseng, Tai-Chung;KAI-WEN HUANG;CHEN-HUA LIU;Liao, Chun-Hsun;TUNG-HUNG SU; TUNG-HUNG SU; Liao, Chun-Hsun; CHEN-HUA LIU; KAI-WEN HUANG; Tseng, Tai-Chung |
| 臺大學術典藏 |
2019-08-29T07:31:54Z |
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging
|
Tung-Hung Su;Liao, Sih-Han;Chun-Ming Hong;Chun-Jen Liu;Tseng, Tai-Chung;Chen-Hua Liu;Hung-Chih Yang;Pei-Jer Chen;Ding-Shinn Chen;Chi-Ling Chen;Adhoute, Xavier;Bourli?Re, Marc;Jia-Horng Kao; TUNG-HUNG SU; Liao, Sih-Han; CHUN-MING HONG; CHUN-JEN LIU; Tseng, Tai-Chung; CHEN-HUA LIU; HUNG-CHIH YANG; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; Adhoute, Xavier; Bourli?re, Marc; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-29T07:31:54Z |
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging
|
Tung-Hung Su;Liao, Sih-Han;Chun-Ming Hong;Chun-Jen Liu;Tseng, Tai-Chung;Chen-Hua Liu;Hung-Chih Yang;Pei-Jer Chen;Ding-Shinn Chen;Chi-Ling Chen;Adhoute, Xavier;Bourli?Re, Marc;Jia-Horng Kao; TUNG-HUNG SU; Liao, Sih-Han; CHUN-MING HONG; CHUN-JEN LIU; Tseng, Tai-Chung; CHEN-HUA LIU; HUNG-CHIH YANG; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; Adhoute, Xavier; Bourli?re, Marc; JIA-HORNG KAO |
